Adrenal Insufficiency Secondary to Peritoneal Dialysis-Related Peritonitis: A Case Report

dc.authoridkurultak, ilhan/0000-0001-5607-1375
dc.authoridGokalp, Cenk/0000-0003-3909-7973
dc.authorwosidGokalp, Cenk/AGW-1853-2022
dc.authorwosidkurultak, ilhan/V-1616-2019
dc.contributor.authorGokalp, Cenk
dc.contributor.authorYildiz, Faruk
dc.contributor.authorTuzun, Simge
dc.contributor.authorKaradag, Gorkem
dc.contributor.authorKurultak, Ilhan
dc.contributor.authorUstundag, Sedat
dc.date.accessioned2024-06-12T10:50:48Z
dc.date.available2024-06-12T10:50:48Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPeritoneal dialysis (PD)-related peritonitis is one of the most important factors affecting the long-term success of PD. Adrenal insufficiency is a clinical manifestation of inadequate production of glucocorticoids with accompanying deficiency of mineralocorticoids and adrenal androgens. We present a 58-year-old PD patient who admitted to hospital with fever, abdominal pain, vomiting, and confusion. The patient was treated with cephazolin and ceftazidime after the confirmation of peritonitis. Despite the resolution of peritonitis after 2 weeks with appropriate antibiotic treatment, the patient continued to suffer from vomiting, hypotension, and confusion. After the evaluation of basal serum cortisol and 250 mu g ACTH stimulation test, the patient had been diagnosed as adrenal insufficiency and treated with fludrocortisone 0.1 mg/day. Patients remaining vomiting, hypotension, and confusion symptoms were corrected after the fludrocortisone therapy. Following 2 months of successful treatment of adrenal insufficiency, the patient had adherence problem with fludrocortisone for 3-4 weeks. On an outpatient visit, serum ACTH and cortisol levels were normal despite the discontinuation of fludrocortisone and so the patient had been evaluated as partial adrenal insufficiency secondary to PD-related peritonitis. In conclusion, adrenal insufficiency should be kept in mind in PD patients suffering from hypotension and peritonitis.en_US
dc.identifier.doi10.1159/000501391
dc.identifier.endpage275en_US
dc.identifier.issn0253-5068
dc.identifier.issn1421-9735
dc.identifier.issue3en_US
dc.identifier.pmid31291617en_US
dc.identifier.scopus2-s2.0-85072848864en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage272en_US
dc.identifier.urihttps://doi.org/10.1159/000501391
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18130
dc.identifier.volume48en_US
dc.identifier.wosWOS:000489175200010en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKargeren_US
dc.relation.ispartofBlood Purificationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAdrenal Insufficiencyen_US
dc.subjectPeritonitisen_US
dc.subjectHypotensionen_US
dc.subjectPeritoneal Dialysisen_US
dc.subjectFludrocortisoneen_US
dc.titleAdrenal Insufficiency Secondary to Peritoneal Dialysis-Related Peritonitis: A Case Reporten_US
dc.typeArticleen_US

Dosyalar